Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”

키워드

참고문헌 (25)

1. Ntellas P, "Updates on systemic therapy for hepatocellular carcinoma", Am Soc Clin Oncol Educ Book, 44, pp.e430028~ (2024)
2. Wan X, "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting", Clin Mol Hepatol, 30, pp.735~755 (2024)
3. Bertoletti A, "T cell receptor-therapy in HBV-related hepatocellularcarcinoma", Oncoimmunology, 4, pp.e1008354~ (2015)
4. Bohne F, "T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes", Gastroenterology, 134, pp.239~247 (2008)
5. June CH, "Principles of adoptive T cell cancer therapy", J Clin Invest, 117, pp.1204~1212 (2007)
6. June CH, "Engineering lymphocyte subsets : tools, trials and tribulations", Nat Rev Immunol, 9, pp.704~716 (2009)
7. Bertoletti A, "Challenges of CAR-and TCR-T cell-based therapy for chronic infections", J Exp Med, 217, pp.e20191663~ (2020)
8. Tan AT, "Use of expression profiles of HBV-DNA integrated into genomes of hepatocellular carcinoma cells to select T cells for immunotherapy", Gastroenterology, 156, pp.1862~1876 (2019)
9. Krebs K, "T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice", Gastroenterology, 145, pp.456~465 (2013)
10. Gehring AJ, "Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines", J Hepatol, 55, pp.103~110 (2011)
11. Banu N, "Building and optimizing a virus-specific T cell receptor library for targeted immunotherapy in viral infections", Sci Rep, 4, pp.4166~ (2014)
12. Wisskirchen K, "Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use", PLoS One, 12, pp.e0182936~ (2017)
13. Kah J, "Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection", J Clin Invest, 127, pp.3177~3188 (2017)
14. Wisskirchen K, "T cell receptor grafting allows virological control of Hepatitis B virus infection", J Clin Invest, 129, pp.2932~2945 (2019)
15. Gehring AJ, "Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma", Gastroenterology, 137, pp.682~690 (2009)
16. Qasim W, "Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient", J Hepatol, 62, pp.486~491 (2015)
17. Meng F, "Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells : results of dose escalation, phase I trial", Hepatol Int, 15, pp.1402~1412 (2021)
18. Tan AT, "Immunological alterations after immunotherapy with short lived HBVTCR T cells associates with long-term treatment response in HBV-HCC", Hepatol Commun, 6, pp.841~854 (2022)
19. Aggarwal A, "Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatmentmediated reductions in HBV core-positive cells", JHEP Rep, 5, pp.100664~ (2022)
20. Koh S, "A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus", Mol Ther Nucleic Acids, 2, pp.e114~ (2013)
21. Porter DL, "Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia", N Engl J Med, 365, pp.725~733 (2011)
22. Suthen S, "Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCC", Hepatology, 76, pp.1329~1344 (2022)
23. Healy K, "Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions", JHEP Rep, 3, pp.100318~ (2021)
24. Schreiber S, "Characterization of a library of 20 HBVspecific MHC class II-restricted T cell receptors", Mol Ther Methods Clin Dev, 23, pp.476~489 (2021)
25. Lin M, "Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole blood", Immunother Adv, 3, pp.ltad015~ (2023)

관련 논문AI추천